Positive Psychology for Irritable Bowel Syndrome

Boston, MA

N/A

Waitlist Available

Led By Elizabeth N Madva, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline (week 1), at the mid-point of the intervention (week 5), post-intervention (week 9), and 3-months post-intervention (week 21)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a new positive psychology intervention called "WISH" is helpful for patients with irritable bowel syndrome. Researchers will compare this new intervention to a control group that receives educational information

See full description

Who is the study for?

This trial is for individuals with Irritable Bowel Syndrome (IBS). Participants should be interested in exploring non-medical treatments focused on mental well-being. Specific eligibility criteria are not provided, but typically include age range, symptom severity, and willingness to adhere to the study protocol.

What is being tested?

The WISH 2.0 study is testing an optimized positive psychology intervention against an educational control intervention to see which one better improves the quality of life for IBS patients. It looks at how acceptable and effective these approaches are and their impact on gut-brain interactions.See study design

What are the potential side effects?

Since this trial involves psychological interventions rather than medications, traditional side effects like those seen with drugs may not apply. However, participants might experience emotional discomfort or fatigue from engaging in the activities required by the interventions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline (week 1), at the mid-point of the intervention (week 5), post-intervention (week 9), and 3-months post-intervention (week 21)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline (week 1), at the mid-point of the intervention (week 5), post-intervention (week 9), and 3-months post-intervention (week 21)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline (week 1), at the mid-point of the intervention (week 5), post-intervention (week 9), and 3-months post-intervention (week 21) for reporting.